MetLife Investment Management’s Holley HLLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127K Buy
49,811
+30,646
+160% +$87K ﹤0.01% 2663
2026
Q1
$58.8K Sell
19,165
-23,198
-55% -$87.9K ﹤0.01% 2664
2025
Q4
$175K Buy
42,363
+19,477
+85% +$70.1K ﹤0.01% 2338
2025
Q3
$71.9K Buy
+22,886
New +$68.2K ﹤0.01% 2758
2024
Q4
– Sell
-9,810
Closed -$28.9K – 2831
2024
Q3
$28.9K Sell
9,810
-21,405
-69% -$71.7K ﹤0.01% 2808
2024
Q2
$112K Buy
31,215
+10,869
+53% +$42.4K ﹤0.01% 2554
2024
Q1
$90.7K Sell
20,346
-9,746
-32% -$44.5K ﹤0.01% 2580
2023
Q4
$147K Hold
30,092
– – ﹤0.01% 2406
2023
Q3
$150K Hold
30,092
– – ﹤0.01% 2363
2023
Q2
$123K Hold
30,092
– – ﹤0.01% 2559
2023
Q1
$82.5K Buy
30,092
+18,713
+164% +$47.8K ﹤0.01% 2628
2022
Q4
$24.1K Sell
11,379
-17,173
-60% -$54.1K ﹤0.01% 2810
2022
Q3
$116K Hold
28,552
– – ﹤0.01% 2607
2022
Q2
$300K Buy
+28,552
New +$311K ﹤0.01% 2024

Other funds holding HLLY

MetLife Investment Management's HLLY Position: Q2 2026 in Review

MetLife Investment Management increased its Holley (HLLY) stake by 160% in Q2 2026, buying an estimated $87K and bringing the position to 49,811 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #2663.

MetLife Investment Management first reported a position in HLLY in Q2 2022 and has held it in 14 quarters since. The position peaked at $300K in Q2 2022. 132 funds tracked by Wall St. Rank hold HLLY as of Q2 2026.

  • MetLife Investment Management held 49,811 shares of Holley worth $127K as of Q2 2026.
  • MetLife Investment Management bought 30,646 Holley shares in Q2 2026, an estimated $87K.
  • Holley made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2663 holding.
  • MetLife Investment Management first reported a position in Holley in Q2 2022 and has held it in 14 quarters since.
  • MetLife Investment Management's Holley position peaked at $300K in Q2 2022.
  • 132 funds tracked by Wall St. Rank held Holley as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.